| top of page |
| Details of the target gene |
| Gene Model of Rodent Parasite |
PBANKA_0926700
|
| Gene Model P. falciparum ortholog |
PF3D7_1121600
|
| Gene product | exported protein 1 | circumsporozoite-related antigen | parasitophorous vacuole membrane antigen QF 116 |
| Gene product: Alternative name | EXP1; CRA; Ag5.1; HEP17 |
| top of page |
| Details of the genetic modification |
| Short description of the mutation | Replacement of the promoter region by the ama1-PBANKA_091500-promoter by 'promoter swap' technology |
| Inducable system used | No |
| Short description of the conditional mutagenesis | Not available |
| Additional remarks inducable system |
|
| Type of plasmid/construct | (Linear) plasmid single cross-over |
| PlasmoGEM (Sanger) construct/vector used | No |
| Modified PlasmoGEM construct/vector used | No
|
| Plasmid/construct map |
|
| Plasmid/construct sequence |
|
| Restriction sites to linearize plasmid |
|
| Selectable marker used to select the mutant parasite | hdhfr/yfcu |
| Promoter of the selectable marker | eef1a |
| Selection (positive) procedure | pyrimethamine |
| Selection (negative) procedure | No |
| Additional remarks genetic modification | Unsuccessful attempts to disrupt the exp1 indicates an essential function (see RMgm-4125).
Also replacement of the exp1 promoter region with the (schizont-specific) ama1 promoter region were unsuccessful. |
| Additional remarks selection procedure | |
Primer information: Primers used for amplification of the target sequences 
Primer information: Primers used for amplification of the target sequences
| Sequence Primer 1 | |
| Additional information primer 1 | |
| Sequence Primer 2 | |
| Additional information primer 2 | |
| Sequence Primer 3 | |
| Additional information primer 3 | |
| Sequence Primer 4 | |
| Additional information primer 4 | |
| Sequence Primer 5 | |
| Additional information primer 5 | |
| Sequence Primer 6 | |
| Additional information primer 6 | |
|
|
| top of page |